Valbiotis

    OverviewSuggest Edit

    Valbiotis is a company that develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. The Company's “Nutrition Healthcare” approach seeks to develop tools designed to prevent type 2 diabetes, NASH (non-alcoholic steatohepatitis) and obesity. Valbiotis' mission is to help millions of people all over the world to live for a longer time, in good health.
    TypePublic
    Founded2014
    HQPerigny, FR
    Websitevalbiotis.com

    Latest Updates

    Employees (est.) (Dec 2017)13

    Valbiotis Office Locations

    Valbiotis has an office in Perigny
    Perigny, FR (HQ)
    Zone Industrielle des 4 Chevaliers, Bâtiment 12F, Rue Paul Vatine
    Show all (1)

    Valbiotis Online and Social Media Presence

    Embed Graph

    Valbiotis Blogs

    VALBIOTIS announces the success of its capital increase with maintenance of the DPS for an amount of 7.2 million euros (in French)

    The article VALBIOTIS announces the success of its capital increase with maintenance of the DPS for an amount of 7.2 million euros (in French) first appeared on Valbiotis.

    VALBIOTIS presents positive results from a study on TOTUM-63, active substance of VALEDIA®, at EASD 2019

    The article VALBIOTIS presents positive results from a study on TOTUM-63, active substance of VALEDIA®, at EASD 2019 first appeared on Valbiotis.

    Additional positive results from the Phase IIA clinical study on VALEDIA® in lipid metabolism and arterial hypertension

    The article Additional positive results from the Phase IIA clinical study on VALEDIA® in lipid metabolism and arterial hypertension first appeared on Valbiotis.

    Provision of the Registration Document (R 19-030) and Statement of cash position as of June 30, 2019 (in French)

    The article Provision of the Registration Document (R 19-030) and Statement of cash position as of June 30, 2019 (in French) first appeared on Valbiotis.

    VALBIOTIS announces positive results from the Phase IIA clinical study of VALEDIA®, now the first product proven effective in people with prediabetes

    The article VALBIOTIS announces positive results from the Phase IIA clinical study of VALEDIA®, now the first product proven effective in people with prediabetes first appeared on Valbiotis.

    VALBIOTIS to present novel data about TOTUM-63 and metabolic diseases prevention at the 2019 scientific sessions of the American Diabetes Association

    The article VALBIOTIS to present novel data about TOTUM-63 and metabolic diseases prevention at the 2019 scientific sessions of the American Diabetes Association first appeared on Valbiotis.
    Show more

    Valbiotis Frequently Asked Questions

    • When was Valbiotis founded?

      Valbiotis was founded in 2014.

    • How many employees does Valbiotis have?

      Valbiotis has 13 employees.

    • Who are Valbiotis competitors?

      Competitors of Valbiotis include One Medical Group, Fullerton Healthcare and Alseres Pharmaceuticals.

    • Where is Valbiotis headquarters?

      Valbiotis headquarters is located at Zone Industrielle des 4 Chevaliers, Bâtiment 12F, Rue Paul Vatine, Perigny.

    • Where are Valbiotis offices?

      Valbiotis has an office in Perigny.

    • How many offices does Valbiotis have?

      Valbiotis has 1 office.